Id1-4 |
Class I and II bHLH proteins |
Dominant negative regulation of bHLH factors |
[61–63, 236] |
Id2 |
pRb and related pocket proteins p107 and p130 |
Inhibition of pRb-mediated cell-cycle arrest (as no interaction between the pRb small pocket and Id2 was detected by mass spectrometry and NMR spectroscopy [136], a multiprotein complex is likely to be formed) |
[64, 65] |
Id2 |
ENH |
Id-protein localization in the cytoplasm by association of the Id2 HLH and ENH LIM domains |
[66, 67] |
Id1-3 |
p204 |
Id-protein localization in the cytoplasm |
[68, 69] |
Id1-3 |
Ets-domain proteins Elk-1 and SAP-1/-2 |
Inhibition of the winged-helix-turn-helix transcription factors regulating the expression of immediate-early response genes such as c-Fos and Egr1 |
[70] |
Id1 |
MIDA1 |
Inhibition of MIDA1-Z-DNA interaction with stimulation of cell growth and inhibition of neural differentiation |
[71, 72, 344, 345] |
Id1-3 |
Pax-2/-5/-8 |
Inhibition of the paired-box transcription factors involved in development |
[73] |
Id1, Id2 |
Adenovirus E1A protein |
Induction of apoptosis in cells expressing p53 mutants |
[74] |
Id2, Id3 |
ADD1/SREBP-1c |
Inhibition of the bHLH-LZ transcription factor that regulates the expression of adipocyte genes |
[75] |
Id1 |
C8, HBX |
Induction of proteasome-mediated HBX degradation |
[76] |
Id1 |
S5a |
Suppression of the Id-protein activity |
[77] |
Id1, Id3 |
CSN5 (Id1, Id3), CSN7 (Id3) |
Suppression of Id-protein ubiquitination by CSN-mediated phosphorylation |
[78] |
Id1-3 |
USP1 |
Id-protein deubiquitination |
[79] |
Id2 |
Apc/C subunits Apc1, Apc5, Apc8/Cdc23 |
Id2-protein degradation |
[50] |
Id1 |
Caveolin-1 |
Induction of cell migration and chemotherapy resistance in prostate cancer |
[80] |
Id1-4 |
FHL2 |
Antagonism of the inhibitory effect of the Id proteins on E47-mediated transcription |
[81] |
Id2 |
VHL-elongin-C |
Inhibition of ubiquitination and degradation of HIF2α |
[82] |
Id1 |
ERβ1 |
Inhibition of cell proliferation and p21 up-regulation |
[83] |